HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Over 15 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in both China and overseas.

Pre-IPO Basecare Medical - Here Are the the Strengths and Concerns

Pre-IPO Raily Aesthetic Medicine (2135.HK) - Here Are the Concerns

JD Health (6618.HK) - Opportunities Coexist with Challenges

Pre-IPO MicroPort CardioFlow - A Better Candidate of the TAVR Market in China?

Yidu Tech (医渡云) Pre-IPO - Forecast and Peer Valuation

Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?

Equity Capital Markets

<p>The past decade has witnessed the rapid development of healthcare informatization in China, resulting in the generation of massive healthcare data. In the general trend of the development of precision medicine, the storage of healthcare data is scattered and low in structure, which has become the bottleneck of its value. Under this background, the scientific research and clinical value of exploiting healthcare data with cutting-edge technology is urgent. Therefore, with the implementation of AI and big data technology in the field of healthcare, a group of medical technology enterprises emerged based on their own technical strength, working with key players in the industry, and developing innovative solutions. In 2014, <a href="https://www.smartkarma.com/entities/yidu-tech-inc" target="_blank" data-smartkarma-citation="entities:29245:1" rel="noopener">Yidu Tech Inc (YID HK)</a> was established and then became an important member in the industry. After the development of about 6 years, recently, Yidu passed the Hong Kong Stock Exchange hearing for its IPO.</p>

The past decade has witnessed the rapid development of healthcare informatization in China, resulting in the generation of massive healthcare data. In the general trend of the development of precision medicine, the storage of healthcare data is scattered and low in structure, which has become the bottleneck of its value. Under this background, the scientific research and clinical value of exploiting healthcare data with cutting-edge technology is urgent. Therefore, with the implementation of AI and big data technology in the field of healthcare, a group of medical technology enterprises emerged based on their own technical strength, working with key players in the industry, and developing innovative solutions. In 2014, Yidu Tech Inc (YID HK) was established and then became an important member in the industry. After the development of about 6 years, recently, Yidu passed the Hong Kong Stock Exchange hearing for its IPO.

Pre-IPO Yidu Tech Inc - The Future Performance Is Worth Looking Forward To